APA (7th ed.) Citation

Lalloo, U. G., Komarow, L., Aberg, J. A., Clifford, D. B., Hogg, E., McKhann, A., . . . Larsen, R. A. (2023). Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Lalloo, Umesh G., et al. Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a Multicentre, Phase I/II, Two-stage, Dose-finding, Safety, Tolerability and Efficacy Randomised, Amphotericin B-controlled Trial of the AIDS Clinical Trials Group. Public Library of Science (PLoS), 2023.

MLA (9th ed.) Citation

Lalloo, Umesh G., et al. Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a Multicentre, Phase I/II, Two-stage, Dose-finding, Safety, Tolerability and Efficacy Randomised, Amphotericin B-controlled Trial of the AIDS Clinical Trials Group. Public Library of Science (PLoS), 2023.